Issuance of Final Guidance Publication, 56078 [2014-22275]
Download as PDF
<![CDATA[
56078
Federal Register / Vol. 79, No. 181 / Thursday, September 18, 2014 / Notices
Dated: September 12, 2014.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
Centers for Disease Control and
Prevention
[CDC–2013–0007; Docket Number NIOSH–
233]
Issuance of Final Guidance Publication
National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC),
Department of Health and Human
Services (HHS).
ACTION: Notice of issuance of final
guidance publication.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2014–22297 Filed 9–17–14; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meetings
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
AGENCY:
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
The National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC)
announces the publication of the
following document entitled ‘‘NIOSH
List of Antineoplastic and Other
Hazardous Drugs in Healthcare Settings,
2014.’’
ADDRESSES: This document is available
at the following link: https://
www.cdc.gov/niosh/docs/2014–138/
pdfs/2014–138.pdf.
FOR FURTHER INFORMATION CONTACT:
Barbara MacKenzie, NIOSH, 1090
Tusculum Avenue, MS–C26, Cincinnati,
Ohio 45226, telephone (513) 533–8132,
email hazardousdrugs@cdc.gov.
SUMMARY:
Dated: September 11, 2014.
John Howard,
Director, National Institute for Occupational
Safety and Health, Centers for Disease Control
and Prevention.
[FR Doc. 2014–22275 Filed 9–17–14; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
asabaliauskas on DSK5VPTVN1PROD with NOTICES
Center for Scientific Review Amended;
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Center for Scientific
Review Special Emphasis Panel,
October 10, 2014, 12:00 p.m. to October
10, 2014, 01:00 p.m., Sir Francis Drake
Hotel, 450 Powell Street at Sutter, San
Francisco, CA 94102 which was
published in the Federal Register on
September 12, 2014, 79 FR 54734.
The meeting will be held at the Pier
2620 Hotel, 2620 Jones Street, San
Francisco, CA 94133. The meeting date
and time remain the same. The meeting
is closed to the public.
VerDate Sep<11>2014
17:27 Sep 17, 2014
Jkt 232001
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Allergy, Immunology,
and Transplantation Research Committee.
Date: October 15–16, 2014.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Room
3147, 6700B Rockledge Drive, Bethesda, MD
20817, (Telephone Conference Call).
Contact Person: James T. Snyder, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities/
NIAID, National Institutes of Health, 6700B
Rockledge Drive, MSC 7616, Bethesda, MD
20892–7616, 301–435–1614, james.snyder@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: September 12, 2014.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–22298 Filed 9–17–14; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel, P41 BTRC review.
Date: October 21–23, 2014.
Time: 6:00 p.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Beechwood Hotel, 363 Plantation
Street, Worcestor, MA 01605.
Contact Person: Manana Sukhareva, Ph.D.,
Scientific Review Officer, National Institute
of Biomedical Imaging and Bioengineering,
National Institutes of Health, 6707
Democracy Boulevard, Room 959, Bethesda,
MD 20892, 301–451–3397, sukharem@
mail.nih.gov.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel, P41 BTRC review.
Date: November 4–6, 2014.
Time: 6:00 p.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Inn at Longwood Medical, 342
Longwood Avenue, Boston, MA 02115.
Contact Person: Manana Sukhareva, Ph.D.,
Scientific Review Officer, National Institute
of Biomedical Imaging and Bioengineering,
National Institutes of Health, 6707
Democracy Boulevard, Room 959, Bethesda,
MD 20892, 301–451–3397, sukharem@
mail.nih.gov.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel, P30 Biomedical
Technology Service Center Review.
Date: December 2, 2014.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, 6707 Democracy
Boulevard, Bethesda, MD 20892.
Contact Person: Manana Sukhareva, Ph.D.,
Scientific Review Officer, National Institute
of Biomedical Imaging and Bioengineering,
National Institutes of Health, 6707
E:\FR\FM\18SEN1.SGM
18SEN1
]]>Agencies
[Federal Register Volume 79, Number 181 (Thursday, September 18, 2014)]
[Notices]
[Page 56078]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-22275]
[[Page 56078]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[CDC-2013-0007; Docket Number NIOSH-233]
Issuance of Final Guidance Publication
AGENCY: National Institute for Occupational Safety and Health (NIOSH)
of the Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of issuance of final guidance publication.
-----------------------------------------------------------------------
SUMMARY: The National Institute for Occupational Safety and Health
(NIOSH) of the Centers for Disease Control and Prevention (CDC)
announces the publication of the following document entitled ``NIOSH
List of Antineoplastic and Other Hazardous Drugs in Healthcare
Settings, 2014.''
ADDRESSES: This document is available at the following link: https://www.cdc.gov/niosh/docs/2014-138/pdfs/2014-138.pdf.
FOR FURTHER INFORMATION CONTACT: Barbara MacKenzie, NIOSH, 1090
Tusculum Avenue, MS-C26, Cincinnati, Ohio 45226, telephone (513) 533-
8132, email hazardousdrugs@cdc.gov.
Dated: September 11, 2014.
John Howard,
Director, National Institute for Occupational Safety and Health,
Centers for Disease Control and Prevention.
[FR Doc. 2014-22275 Filed 9-17-14; 8:45 am]
BILLING CODE 4163-19-P
